Monitoring psoriasis patients being treated with tumour necrosis factor inhibitors: use your judgment

Authors


  • Conflicts of interest
    S.R.F. has received research, speaking and/or consulting support from Abbott, Amgen, Astellas, Centocor, Galderma, GSK/Stiefel and National Biological Corporation.

No abstract is available for this article.

Ancillary